KRM Ayurveda IPO GMP & Review: Apply or Avoid?

KRM Ayurveda IPO is open for bidding from 19th January 2026 to 21st January 2026. It is a bookbuilding IPO of ₹77.49 crore, an entirely fresh issue of 0.57 crore shares. The issue will be listed on NSE and SME on its tentative listing date, 27th January 2026. 

KRM Ayurveda IPO Details 

The KRM Ayurveda IPO date is fixed between 19th January 2026 and 21st January 2026. The face value of KRM Ayurveda shares stands at ₹10 per share, and the IPO Issue price band is set at ₹128 to ₹135 per share

Skyline Financial ServicesPrivate Limited is the registrar of the KRM Ayurveda IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest IPO details in the table below. 

KRM Ayurveda IPO Share Reservation

Riddhi Display Equipment’s IPO is a bookbuilding issue of 0.57 crore shares worth ₹77.49 crore. KRM Ayurveda IPO Limited shares will be listed on the NSE and the SME Exchange. Furthermore, SEBI has specified the share reservation criteria for different investor categories. 

KRM Ayurveda IPO GMP Grey Market Premium

GMP is the gap between the issue price band and the price at which company shares are currently trading in the grey market. Do you want to get live updates on the KRM Ayurveda IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.

As of 19th January 2026, KRM Ayurveda IPO GMP stands at ₹15.00 per share, which means the share will likely list at ₹150.00 on its tentative listing date, 27th January 2026.

GMP data is subject to change based on market trends and sentiments. You should check the live GMP status before applying for the KRM Ayurveda IPO GMP. Stay informed with Univest for real-time insights into IPOs and their GMP trends. 

KRM Ayurveda IPO GMP Review

Check out the detailed KRM Ayurveda GMP IPO review for a thorough understanding of its potential to report listing gains on 27th January 2026. The KRM Ayurveda IPO review below will help you invest effectively to avoid significant losses. Explore more to make informed investment decisions on this IPO. 

Financial Health

Assess a company’s financial performance to know about its ability to sustain a competitive edge. Thus, it is essential to understand the business’s economic growth and decline before applying for the KRM Ayurveda IPO.

KRM Ayurveda Limited’s revenue increased by 13.88% from ₹67.57 crores in March 2024 to ₹76.95 crores in March 2025. Moreover, the company’s PAT increased by 254.83% from ₹3.41 crores in March 2024 to ₹12.10 crores in March 2025.

KRM Ayurveda’s IPO has shown consistent revenue growth, indicating the company’s financial stability. Moreover, brokers, investors, and RAs have a positive outlook for the KRM Ayurveda IPO, with its tentative listing day set for 27th January 2026. 

Technical Analysis

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technicals of the KRM Ayurveda IPO.

The P/E ratio of KRM Ayurveda Limited shares is 1732, and its Earnings Per Share (EPS) stands at 7.79. Thus, the KRM Ayurveda IPO can deliver gains on its tentative listing date, 27th January 2026. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of KRM Ayurveda Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

KRM Ayurveda IPO Subscription Status

The KRM Ayurveda IPO will open for bidding on 19th January 2026. The subscription status for this IPO is yet to be announced. Stay informed on this passage to check the live KRM Ayurveda IPO Subscription Status. 

About KRM Ayurveda Limited

KRM Ayurveda Limited was established on 3 September 2019. KRM Ayurveda Ltd. operates a network of hospitals and clinics across multiple cities in India and has also marked its presence abroad through telemedicine consulting and sales. They manufacture Ayurvedic products, herbal and botanical remedies, medicines, supplements and possibly skin care/wellness-related items. Presently, the company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in the country. Hospitals and Clinics are equipped with the following infrastructure & facilities:

• Beds, including general wards and premium rooms.
• Panchakarma treatment units.
• Herbal pharmacy and medicine preparation unit.
• Ayurvedic diet kitchen
• Consultation chambers for Vaidyas (Ayurvedic physicians).
• In-house yoga and meditation hall.

KRM Ayurveda Limited Financials

The company’s financial analysis is essential before applying for the KRM Ayurveda IPO. Look at the table to learn about KRM Ayurveda Limited’s financials. 

Explanation

KRM Ayurveda Limited’s revenue increased by 13.88% from ₹67.57 crores in March 2024 to ₹76.95 crores in March 2025. Moreover, the company’s PAT increased by 254.83% from ₹3.41 crores in March 2024 to ₹12.10 crores in March 2025.

KRM Ayurveda Limited IPO Promoter Holdings

Have a look at the table below to check the holdings of Ashish Kankaria, Shruti A. Kankaria, Ambica Capital Markets Limited, and Gold View Financial Services Limited.

Note: The value will be calculated using Equity Dilution = Share Holding Pre Issue – Share Holding Post Issue.

Aim of the KRM Ayurveda IPO

The primary aim of the KRM Ayurveda IPO is to raise ₹77.49 crores. On the other hand, KRM Ayurveda has decided to utilise these funds in different ways.

• To Capital Expenditure for Construction and Development of Telemedicine Operational Facilities
• To purchase CRM Software and Hardware Infrastructure
• To General Corporate Expenses.
• To Human Resources
• To Repayment/Prepayment of loan
• To Working Capital Requirement

Should I Invest in the KRM Ayurveda IPO?

Explore the pros and cons of KRM Ayurveda to know whether you should apply or avoid the issue. These pros and cons might help you understand the IPO’s efficiency in delivering profits over the coming decades. 

Pros of the KRM Ayurveda IPO

• The company has skilled Ayurvedic physicians and certified therapists, ensuring treatment quality.
• The company has a trusted brand with a loyal customer base and repeat clientele.
• The company has a centralised GMP-certified production facility for Ayurvedic medicines, ensuring purity and efficacy.

Cons of the KRM Ayurveda IPO

• The company relies on leased properties.
• The company has high employee attrition.
• The company has a geographic concentration of revenue.

How to Apply for the KRM Ayurveda IPO?

Check the steps mentioned below to apply for KRM Ayurveda Ltd.

• Step 1: Conduct thorough research on the KRM Ayurveda IPO GMP, subscription status, issue size, lot size, and other details. 
• Step 2: Open a demat account with Univest to access real-time insights on GMP and subscription status. You can also use your previous demat account by navigating to the IPO section. 
• Step 3: Make a bid for 2 lots of 2,000 shares worth ₹2,70,000
• Step 4: You will receive a mandate request after making a bid. Approve the request to proceed further.    

Note: You can apply for the KRM Ayurveda IPO across multiple demat accounts to increase your chances of allotment. 

How to Check the KRM Ayurveda IPO Allotment Status?

You can check for the KRM Ayurveda IPO allotment in different ways. These include NSE and the registrar portal. Follow the steps below to check your allotment status online.

Check On NSE

• Visit the NSE Official Site
• Navigate to the IPO Allotment Section. 
• Select Equity as the issue type. 
• Choose the KRM Ayurveda IPO.  
• Choose whether to proceed with the PAN number or the application number.
• Submit your details to get the allotment status online. 

Check On the Registrar Portal

• Visit the registrar portal.
• Click on the allotment option.
• Fill in the required details.
• Click on the submit button to know your KRM Ayurveda IPO allotment status.

Let’s Wrap

KRM Ayurveda IPO is a bookbuilding issue of shares worth ₹77.49 crores. The shares of KRM Ayurveda Limited will be listed on NSE and SME on its tentative listing date of 27th January 2026. Researching the KRM Ayurveda IPO GMP and reviews is highly recommended to achieve your desired profitability. Brokers and investors have highlighted their pros and cons, so one must analyse them and decide accordingly.

Open a demat account on Univest now to initiate your investment journey!

FAQs on KRM Ayurveda IPO

How is the KRM Ayurveda IPO?

Ans. Currently, on 19th January 2026, the KRM Ayurveda GMP (Grey Market Premium) stands at ₹15. It indicates that the estimated listing price could be ₹150 per share. It is a bookbuilding IPO of ₹77.49 shares. The face value of each KRM Ayurveda share is ₹10 per share. 

What is the KRM Ayurveda IPO price?

Ans. The KRM Ayurveda IPO issue price band is set at ₹128 to ₹135 per share. 

Is the KRM Ayurveda IPO a good investment?

Ans. KRM Ayurveda Limited’s revenue increased by 13.88% from ₹67.57 crores in March 2024 to ₹76.95 crores in March 2025. Moreover, the company’s PAT increased by 254.83% from ₹3.41 crores in March 2024 to ₹12.10 crores in March 2025.

Who is the registrar of the KRM Ayurveda IPO?

Ans. Skyline Financial Services Private Limited is the registrar for the KRM Ayurveda IPO, awaiting the allotment process and initiating refunds. For any queries regarding the KRM Ayurveda allotment and refund, you can contact Skyline Financial Services Private Limited at 

ipo@skylinerta.com or at 02228511022.

What is the issue size of the KRM Ayurveda IPO? 

Ans. KRM Ayurveda IPO is a bookbuilding IPO of ₹77.49 crores. Moreover, the IPO is set to open on 19th January 2026 and close on 21st January 2026. 

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the KRM Ayurveda IPO, download the KRM Ayurveda IPO RHP and KRM Ayurveda IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Upcoming IPOs

Current & Previous IPOs

Read Our Articles on the Best Stocks

Tech Stocks in India to Invest in 2025 | Tech Sector Stocks 

Best Battery Stocks in India to Invest in 2025 | Battery Sector Stocks 

Best Shipping Stocks in India to Invest in 2025 | Shipping Sector Stocks 

Paint Stocks in India to Invest in 2025 | Paint Sector Stocks 

Paper Stocks in India to Invest in 2025 | Paper Sector Stocks 

Best Semiconductor Stocks in India 2025 

Best Large Cap Stocks in India 2025 

Green Energy Penny Stocks

Best Cement Stocks To Invest In India

Also Explore

Univest Screeners

Explore Webstories on Univest 

Best Time To Buy Dividend Stocks

How RBI Policies Affect Dividend Stocks

Can Dividend Stocks Beat Inflation

What Is The Dividend Aristocrat List

Which Indian Psus Offer The Best Dividends

Large Cap Vs Small Cap Dividend Stocks